With a market capitalization (market cap) of $3.08B — a measure of how much the company is worth — Disc Medicine, Inc. is the 1794th most valuable company in Healthcare as of August 19, 2026. Shares trade at $80.20, up +0.19% on the day.
of 2,587
price ÷ annual EPS
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
Visit websiteAs of August 19, 2026, Disc Medicine, Inc. (IRON) is worth $3.08B — this is its market capitalization, the total value of all its outstanding shares.
Disc Medicine, Inc.’s market cap is $3.08B, which ranks it #1794 among the most valuable companies in the Healthcare sector tracked on MarketCapLens.
Disc Medicine, Inc. (IRON) shares trade at $80.20, up 0.19% on the day, as of August 19, 2026.
Fundamentals are annual. Figures labeled with their fiscal year.
FY 2025